Clinical Trial

A Mass Balance Study Of 14C-RAY1225 Injection In Healthy Chinese Participants

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is an open-label, single-center, single-dose study.
Trial Details
NCT Number NCT07460284
Lead Sponsor Guangdong Raynovent Biotech Co., Ltd
Conditions Basic Science
Enrollment 8 participants
Start Date 2026-03-15
Primary Completion 2026-10-14 (estimated)
Study Completion 2026-10-28 (estimated)
Updated on ClinicalTrials.gov 2026-03-10